These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2437960)

  • 1. Semisynthetic engineering of proteinase inhibitor homologues.
    Tschesche H; Beckmann J; Mehlich A; Schnabel E; Truscheit E; Wenzel HR
    Biochim Biophys Acta; 1987 May; 913(1):97-101. PubMed ID: 2437960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semisynthetic aprotinin derivatives with specific alterations at the reactive-site peptide bond can be used to study structure-function relationships.
    Mehlich A; Beckmann J; Wenzel HR; Tschesche H
    Biochim Biophys Acta; 1989 Jun; 996(1-2):23-9. PubMed ID: 2472174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of chemically 'mutated' aprotinin homologues by semisynthesis. P1 substitutions change inhibitory specificity.
    Beckmann J; Mehlich A; Schröder W; Wenzel HR; Tschesche H
    Eur J Biochem; 1988 Oct; 176(3):675-82. PubMed ID: 2458925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant aprotinin homologue with new inhibitory specificity for cathepsin G.
    Brinkmann T; Schnierer S; Tschesche H
    Eur J Biochem; 1991 Nov; 202(1):95-9. PubMed ID: 1718753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semisynthetic arginine-15-aprotinin, an improved inhibitor for human plasma kallikrein.
    Tschesche H; Beckmann J; Mehlich A; Feldmann A; Wenzel HR; Scott CF; Colman RW
    Adv Exp Med Biol; 1989; 247B():15-21. PubMed ID: 2481943
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzymatic semisynthesis of aprotinin homologues mutated in P' positions.
    Groeger C; Wenzel HR; Tschesche H
    J Protein Chem; 1991 Apr; 10(2):245-51. PubMed ID: 1718310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evolutionarily conserved binding site for serine proteinase inhibitors in large conductance calcium-activated potassium channels.
    Moss GW; Marshall J; Morabito M; Howe JR; Moczydlowski E
    Biochemistry; 1996 Dec; 35(50):16024-35. PubMed ID: 8973172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.
    Scheidig AJ; Hynes TR; Pelletier LA; Wells JA; Kossiakoff AA
    Protein Sci; 1997 Sep; 6(9):1806-24. PubMed ID: 9300481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic 13-residue peptide designed to resemble the primary binding site of the basic pancreatic trypsin inhibitor.
    Kitchell JP; Dyckes DF
    Biochim Biophys Acta; 1982 Feb; 701(1):149-52. PubMed ID: 6173072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical semisynthesis of aprotinin homologues and derivatives mutated in P' positions.
    Groeger C; Wenzel HR; Tschesche H
    J Protein Chem; 1991 Oct; 10(5):527-33. PubMed ID: 1724726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semisynthesis of Arg15, Glu15, Met15, and Nle15-aprotinin involving enzymatic peptide bond resynthesis.
    Beckmann J; Mehlich A; Schröder W; Wenzel HR; Tschesche H
    J Protein Chem; 1989 Feb; 8(1):101-13. PubMed ID: 2475133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and isolation of the bactericidal domains in the proteinase inhibitor aprotinin.
    Pellegrini A; Thomas U; Bramaz N; Klauser S; Hunziker P; von Fellenberg R
    Biochem Biophys Res Commun; 1996 May; 222(2):559-65. PubMed ID: 8670244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of the active derivative of bovine trypsin-kallikrein inhibitor (Kunitz) with open peptide bond in the reactive site.
    Jering H; Tschesche H
    Angew Chem Int Ed Engl; 1974 Oct; 13(10):660-1. PubMed ID: 4215341
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteinase catalyzed resynthesis of the peptide bond Lys 15--Ala 16 in the derivative of trypsin-kallikrein inhibitor (Kunitz) with this peptide bond hydrolyzed.
    Jering H; Tschesche H
    Angew Chem Int Ed Engl; 1974 Oct; 13(10):661-2. PubMed ID: 4215342
    [No Abstract]   [Full Text] [Related]  

  • 15. Kallikrein inhibitors.
    Fritz H; Fink E; Truscheit E
    Fed Proc; 1979 Dec; 38(13):2753-9. PubMed ID: 315885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the solid-phase synthesis of bovine pancreatic trypsin inhibitor (Kunitz) and the characterization of the synthetic material.
    Tan NH; Kaiser ET
    J Org Chem; 1976 Aug; 41(17):2787-93. PubMed ID: 1086350
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization and sequence determination of six aprotinin homologues from bovine lungs.
    Siekmann J; Wenzel HR; Schröder W; Tschesche H
    Biol Chem Hoppe Seyler; 1988 Mar; 369(3):157-63. PubMed ID: 2453200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Native-like conformations are sampled by partially folded and disordered variants of bovine pancreatic trypsin inhibitor.
    Tulla-Puche J; Getun IV; Woodward C; Barany G
    Biochemistry; 2004 Feb; 43(6):1591-8. PubMed ID: 14769035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotinin.
    Belorgey D; Dirrig S; Amouric M; Figarella C; Bieth JG
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):555-60. PubMed ID: 8573092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary trace analysis of the Kunitz/BPTI family of proteins: functional divergence may have been based on conformational adjustment.
    Pritchard L; Dufton MJ
    J Mol Biol; 1999 Jan; 285(4):1589-607. PubMed ID: 9917399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.